Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

paclitaxel/sirolimus-conjugated levulinic acid-linked poly(ethylene glycol)-block-poly(β-benzyl L-aspartate) nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

1

Paclitaxel-conjugated levulinic acid-linked poly(ethylene glycol)-block-poly(β-benzyl L-aspartate)

PEG-LEV-PTX PEG-LEV-PX
Type Polymer
Formula
Role raw materials
2

rapamycin-conjugated levulinic acid-linked poly(ethylene glycol)-block-poly(β-benzyl L-aspartate)

PEG-LEV-RAP
Type Polymer
Formula
Role raw materials

Properties

Applications

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • rapamycin-conjugated levulinic acid-linked poly(ethylene glycol)-block-poly(β-benzyl L-aspartate)
  • Paclitaxel-conjugated levulinic acid-linked poly(ethylene glycol)-block-poly(β-benzyl L-aspartate)
  1. feTW6gYLXUJh5RMpRt
Product

paclitaxel/sirolimus-conjugated levulinic acid-linked poly(ethylene glycol)-block-poly(β-benzyl L-aspartate) nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial